The Discounted Cash Flow (DCF) valuation of Sangamo Therapeutics Inc (SGMO) is (11.44) USD. With the latest stock price at 0.54 USD, the upside of Sangamo Therapeutics Inc based on DCF is -2232.8%.
Based on the latest price of 0.54 USD and our DCF valuation, Sangamo Therapeutics Inc (SGMO) is a sell. selling SGMO stocks now will result in a potential gain of 2232.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.3% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (27.36) - (7.42) | (11.44) |
| Upside | -5202.8% - -1482.9% | -2232.8% |